Telomere length changes after umbilical cord blood transplant

Brian L. Pipes, Tom Tsang, Shu Xin Peng, Roger Fiederlein, Michael Graham, David T. Harris

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

BACKGROUND: The establishment of donor-derived hematopoiesis in the recipients of hematopoietic stem cell (HSC) transplants involves extensive proliferation and differentiation of HSCs. Data from long-term survivors of HSC transplants suggest that these transplanted HSCs may experience a debilitating replicative senescence. A significant posttransplant shortening of peripheral blood mononuclear cell (PBMNC) telomeres has been observed in both marrow transplant and peripheral blood progenitor cell transplant recipients. Similar studies have not been performed for umbilical cord blood (UCB) HSC transplants, which might be expected to exhibit increased posttransplant replicative potential due to their inherently greater telomere length. STUDY DESIGN AND METHODS: Blood was obtained from donor-recipient pairs of allogeneic PBHSC transplant and UCB HSC transplant, both before transplant and at follow-up treatments (minimum 1 year after transplant) after engraftment. Telomere restriction fragment length (TRFL) analysis was performed on the blood samples. The mean TRFL and posttransplant changes in the mean TRFL were analyzed. RESULTS: Measurements of telomere lengths in the PBMNCs of transplant patients revealed a significant net decrease in telomere length in all transplant recipients compared with their respective donors. Our results also revealed that the PBMNCs of umbilical cord stem cell transplant patients retain a significantly longer posttransplant telomere length. CONCLUSION: The significantly longer telomeres observed in the allogeneic UCB HSC transplant recipients compared to the allogeneic PBHSC transplant recipients in our study may be indicative of a replicative advantage inherent in the use of UCB HSC for transplant.

Original languageEnglish (US)
Pages (from-to)1038-1043
Number of pages6
JournalTransfusion
Volume46
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Telomere
Fetal Blood
Transplants
Hematopoietic Stem Cells
Tissue Donors
Blood Cells
Stem Cells
Umbilical Cord
Cell Aging
Hematopoiesis
Survivors
Bone Marrow

ASJC Scopus subject areas

  • Hematology
  • Immunology

Cite this

Pipes, B. L., Tsang, T., Peng, S. X., Fiederlein, R., Graham, M., & Harris, D. T. (2006). Telomere length changes after umbilical cord blood transplant. Transfusion, 46(6), 1038-1043. https://doi.org/10.1111/j.1537-2995.2006.00839.x

Telomere length changes after umbilical cord blood transplant. / Pipes, Brian L.; Tsang, Tom; Peng, Shu Xin; Fiederlein, Roger; Graham, Michael; Harris, David T.

In: Transfusion, Vol. 46, No. 6, 06.2006, p. 1038-1043.

Research output: Contribution to journalArticle

Pipes, BL, Tsang, T, Peng, SX, Fiederlein, R, Graham, M & Harris, DT 2006, 'Telomere length changes after umbilical cord blood transplant', Transfusion, vol. 46, no. 6, pp. 1038-1043. https://doi.org/10.1111/j.1537-2995.2006.00839.x
Pipes, Brian L. ; Tsang, Tom ; Peng, Shu Xin ; Fiederlein, Roger ; Graham, Michael ; Harris, David T. / Telomere length changes after umbilical cord blood transplant. In: Transfusion. 2006 ; Vol. 46, No. 6. pp. 1038-1043.
@article{1718232be42345f8b93f4bd698c7112a,
title = "Telomere length changes after umbilical cord blood transplant",
abstract = "BACKGROUND: The establishment of donor-derived hematopoiesis in the recipients of hematopoietic stem cell (HSC) transplants involves extensive proliferation and differentiation of HSCs. Data from long-term survivors of HSC transplants suggest that these transplanted HSCs may experience a debilitating replicative senescence. A significant posttransplant shortening of peripheral blood mononuclear cell (PBMNC) telomeres has been observed in both marrow transplant and peripheral blood progenitor cell transplant recipients. Similar studies have not been performed for umbilical cord blood (UCB) HSC transplants, which might be expected to exhibit increased posttransplant replicative potential due to their inherently greater telomere length. STUDY DESIGN AND METHODS: Blood was obtained from donor-recipient pairs of allogeneic PBHSC transplant and UCB HSC transplant, both before transplant and at follow-up treatments (minimum 1 year after transplant) after engraftment. Telomere restriction fragment length (TRFL) analysis was performed on the blood samples. The mean TRFL and posttransplant changes in the mean TRFL were analyzed. RESULTS: Measurements of telomere lengths in the PBMNCs of transplant patients revealed a significant net decrease in telomere length in all transplant recipients compared with their respective donors. Our results also revealed that the PBMNCs of umbilical cord stem cell transplant patients retain a significantly longer posttransplant telomere length. CONCLUSION: The significantly longer telomeres observed in the allogeneic UCB HSC transplant recipients compared to the allogeneic PBHSC transplant recipients in our study may be indicative of a replicative advantage inherent in the use of UCB HSC for transplant.",
author = "Pipes, {Brian L.} and Tom Tsang and Peng, {Shu Xin} and Roger Fiederlein and Michael Graham and Harris, {David T.}",
year = "2006",
month = "6",
doi = "10.1111/j.1537-2995.2006.00839.x",
language = "English (US)",
volume = "46",
pages = "1038--1043",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Telomere length changes after umbilical cord blood transplant

AU - Pipes, Brian L.

AU - Tsang, Tom

AU - Peng, Shu Xin

AU - Fiederlein, Roger

AU - Graham, Michael

AU - Harris, David T.

PY - 2006/6

Y1 - 2006/6

N2 - BACKGROUND: The establishment of donor-derived hematopoiesis in the recipients of hematopoietic stem cell (HSC) transplants involves extensive proliferation and differentiation of HSCs. Data from long-term survivors of HSC transplants suggest that these transplanted HSCs may experience a debilitating replicative senescence. A significant posttransplant shortening of peripheral blood mononuclear cell (PBMNC) telomeres has been observed in both marrow transplant and peripheral blood progenitor cell transplant recipients. Similar studies have not been performed for umbilical cord blood (UCB) HSC transplants, which might be expected to exhibit increased posttransplant replicative potential due to their inherently greater telomere length. STUDY DESIGN AND METHODS: Blood was obtained from donor-recipient pairs of allogeneic PBHSC transplant and UCB HSC transplant, both before transplant and at follow-up treatments (minimum 1 year after transplant) after engraftment. Telomere restriction fragment length (TRFL) analysis was performed on the blood samples. The mean TRFL and posttransplant changes in the mean TRFL were analyzed. RESULTS: Measurements of telomere lengths in the PBMNCs of transplant patients revealed a significant net decrease in telomere length in all transplant recipients compared with their respective donors. Our results also revealed that the PBMNCs of umbilical cord stem cell transplant patients retain a significantly longer posttransplant telomere length. CONCLUSION: The significantly longer telomeres observed in the allogeneic UCB HSC transplant recipients compared to the allogeneic PBHSC transplant recipients in our study may be indicative of a replicative advantage inherent in the use of UCB HSC for transplant.

AB - BACKGROUND: The establishment of donor-derived hematopoiesis in the recipients of hematopoietic stem cell (HSC) transplants involves extensive proliferation and differentiation of HSCs. Data from long-term survivors of HSC transplants suggest that these transplanted HSCs may experience a debilitating replicative senescence. A significant posttransplant shortening of peripheral blood mononuclear cell (PBMNC) telomeres has been observed in both marrow transplant and peripheral blood progenitor cell transplant recipients. Similar studies have not been performed for umbilical cord blood (UCB) HSC transplants, which might be expected to exhibit increased posttransplant replicative potential due to their inherently greater telomere length. STUDY DESIGN AND METHODS: Blood was obtained from donor-recipient pairs of allogeneic PBHSC transplant and UCB HSC transplant, both before transplant and at follow-up treatments (minimum 1 year after transplant) after engraftment. Telomere restriction fragment length (TRFL) analysis was performed on the blood samples. The mean TRFL and posttransplant changes in the mean TRFL were analyzed. RESULTS: Measurements of telomere lengths in the PBMNCs of transplant patients revealed a significant net decrease in telomere length in all transplant recipients compared with their respective donors. Our results also revealed that the PBMNCs of umbilical cord stem cell transplant patients retain a significantly longer posttransplant telomere length. CONCLUSION: The significantly longer telomeres observed in the allogeneic UCB HSC transplant recipients compared to the allogeneic PBHSC transplant recipients in our study may be indicative of a replicative advantage inherent in the use of UCB HSC for transplant.

UR - http://www.scopus.com/inward/record.url?scp=33744472194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744472194&partnerID=8YFLogxK

U2 - 10.1111/j.1537-2995.2006.00839.x

DO - 10.1111/j.1537-2995.2006.00839.x

M3 - Article

C2 - 16734822

AN - SCOPUS:33744472194

VL - 46

SP - 1038

EP - 1043

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 6

ER -